MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mersana Therapeutics (MRSN) Ownership - Who owns Mersana Therapeutics?

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
840 Memorial Drive
Phone
+1 617 498-0020
Employees
123
Web
https://www.mersana.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
145.36M
P/E Ratio
N/A
Total Cash
56.39M
Projected Growth
N/A
Total Debt
2.29M
Revenue
33.18M
Risk (Beta)
0.76
Dividend Yield
N/A
Total Cash/Share
11.28
Total Debt/Equity
N/A
Revenue/Share
6.67 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for MRSN
A.I. Advisor
published General Information

General Information

a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
840 Memorial Drive
Phone
+1 617 498-0020
Employees
123
Web
https://www.mersana.com